Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16977255 | 1.00 | TSHR (0.63) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL12891098 | 0.96 | TSHR (0.64) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL16804531 | 0.96 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL14000519 | 0.93 | SMN1; SMN2 (0.68) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL1001533 | 0.93 | TSHR (0.55) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL329824 | 0.93 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL26664442 | 0.93 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL10015522 | 0.93 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL19448719 | 0.93 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL27230054 | 0.93 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1513 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688250-A1 | METHODS FOR MAKING FLOW CELL SURFACES | Illumina, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260008909-A1 | RESIN COMPOSITION AND FLOW CELLS INCORPORATING THE SAME | ILLUMINA INC (US) | 2026-01-08 | — | — | US | claimed |
| US-12415906-B2 | Resin composition and flow cells incorporating the same | ILLUMINA, INC. (US) | 2025-09-16 | — | — | US | claimed |
| US-12418272-B2 | Quartz crystal resonator unit, electronic component, and electronic device | MURATA MANUFACTURING CO., LTD. (JP) | 2025-09-16 | — | — | US | claimed |
| CN-119899492-B | Preparation method of modified polyurethane toughened epoxy resin | 湖北珍正峰新材料有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120155169-A | For CO2Adsorbed amino modified mesoporous polydivinylbenzene material, and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2025-06-17 | — | — | CN | claimed |
| CN-115602917-B | Gel polymer electrolyte precursor, electrolyte, gel battery and method | 陕西煤业化工技术研究院有限责任公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119979089-A | Repair material for improving repair durability of historic building wood components and preparation method thereof | 中国建筑第五工程局有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-12287574-B2 | Resin composition and flow cells incorporating the same | ILLUMINA, INC. (US) | 2025-04-29 | — | — | US | claimed |
| CN-119899492-A | Preparation method of modified polyurethane toughened epoxy resin | 湖北珍正峰新材料有限公司 | 2025-04-29 | — | — | CN | claimed |
| US-6498200-B1 | OXIRANE OR OXETANE RING COMPOUND, ORGANIC PEROXIDE, ONIUM SALT CATALYST, AND ALKALINE FILLER; CURES RAPIDLY; STABLE DOES NOT CAUSE INCREASE IN ELECTROCONDUCTIVITY OR CORROSION; SEALANT, BINDER, ENCAPSULATING AGENT, DIELECTRIC FILM | NAMICS CORPORATION (JP) | 2002-12-24 | — | — | US | claimed |
| US-5773497-A | BLEND OF CARBOXY GROUP CONTAINING RESIN, SILICONES ANDSOLVENT | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1998-06-30 | — | — | US | claimed |
| US-5714238-A | NICKEL OR NICKEL-BORON ALLOY CONDUCTIVE PARTICLES SURFACE TREATED WITH POLYOXYALKYLENE PHOSPHATE COMPOUND AND POLYOXYALKYLENEALKYL AMINE; EPOXY COMPOUND, PHENOLIC RESIN | NAMICS CORPORATION (JP) | 1998-02-03 | — | — | US | claimed |
| EP-0449292-B1 | Multilayer printed circuit board and production thereof | HITACHI LTD (JP) | 1997-08-20 | — | — | EP | claimed |
| EP-0594175-B1 | Process for producing aromatic polycarbonate | MITSUBISHI CHEM CORP (JP) | 1997-06-18 | — | — | EP | claimed |
| US-5391691-A | Melt condensing am aromatic diol compound and a carbonic acid diester in the presence of an interesterification catalyst and co-presence of an organosilicon compound | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1995-02-21 | — | — | US | claimed |
| EP-0594175-A1 | Process for producing aromatic polycarbonate | MITSUBISHI CHEMICAL CORPORATION (JP) | 1994-04-27 | — | — | EP | claimed |
| EP-0202594-B1 | HYDROPHILIC SILICONE RUBBER MOULDINGS AND PROCESS FOR PREPARING THESE | CIBA-GEIGY AG (CH) | 1992-08-05 | — | — | EP | claimed |
| US-4920184-A | Surface treatment with organosiloxane | CIBA-GEIGY CORPORATION (US) | 1990-04-24 | — | — | US | claimed |
| EP-0202594-A2 | Hydrophilic silicone rubber mouldings and process for preparing these | CIBA-GEIGY AG (CH) | 1986-11-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008909-A1 | RESIN COMPOSITION AND FLOW CELLS INCORPORATING THE SAME | CD47, LCP1, DEGS1 | TSHR 3644/4885SMN1; SMN2 4122/4885ALDH1A1 547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.